Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Entero Therapeutics Inc
ENTO
Healthcare
Biotechnology
Entero Therapeutics, Inc., formerly First Wave BioPharma, Inc., is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. Its programs address unmet needs in GI health and include latiglutenase, a Phase III-ready, oral biotherapeutic designed to aid gluten digestion and potentially reduce symptoms of...
celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for multiple GI conditions, including gastroparesis, and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. The Company also intends to develop Niclosamide, an oral small molecule anti-inflammatory inhibitor therapy for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis, and immune checkpoint inhibitor-associated colitis and diarrhea in metastatic cancer patients.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ENTO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 10, 2022 1:52pm
FWBI ...get ready ...Time to put on your.....
Rally Hat..... Market is getting bids At least DJIA & SPY & NSDQ
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 10, 2022 1:10pm
FWBI .... How low will this go you ask ?
All I can tell you is that Mr. Maggot will own all your paper....but not mine ; ) Cheers !
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 10, 2022 11:20am
FWBI...... Mr. Maggot wants all your paper... LMFAO
Keep your "powder keg" dry U just might need it Cheers !
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 10, 2022 7:00am
New Press Release - First Wave BioPharma Presents Research Demonstrating Benefits of Improved Adrulipase Drug Delivery Formulation at AAPS 2022 PharmSci 360
Poster presentation indicates new microgranule formulation elicited desired delayed release profile, offering protection at acidic pH and rapid release under intestinal conditions BOCA RATON, Fla., Oct. 10, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave...
read article.
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Oct 08, 2022 3:45pm
RE:FWBI ....here I am pumping my own "Book" again LoL
Definetly worth a repeat : ) Stick & Stay I always say !!
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 07, 2022 3:03pm
FWBI ..... I'm back
Looks like a lot of posturing going on..... Mr. Maggot is facking with your heads. LoL No Volime ....just changing Bids & Offers are meaningless He's waiting for the weak hands to fall off
...more
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 07, 2022 12:26pm
FWBI.....sorry for the hasty post
Still in this .... just thought I would let u know. Cheers & have a great weekend!!
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 07, 2022 11:57am
FWBI ..... Done for the day !
C u on next week ; )
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 07, 2022 10:52am
FWBI ..... The H.O.D this a.m was $2.05
on a volume of ~ 710K shares Share price is in PB mode after that run up.... The Financing was at $1.75...... LMFAO.....do you seriously think the "Fat Cats" are content making 25 cent ???
...more
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 07, 2022 10:34am
FWBI ....here I am pumping my own "Book" again LoL
The interesting thing I find right now is the volume is still low....that tells me this isn't even close to "Prime Time" Hang in there Folks....we just might have winner !!!!
...more
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 07, 2022 10:25am
FWBI ...This was posted pre RS..we just might get there ; )
Catalysts Abound for FWBI | Opportunity Research (goldmanresearch.com)
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 07, 2022 9:46am
FWBI....... GM Bulls ; )
Stick & stay to make it pay..... I always say ; ) ps: I bot ATXI also
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 07, 2022 6:35am
FWBI ..... Take a look at ATXI...Compare both P.O's
ATXI is a Nano Floater that just announced a P.O yesterday after the close at 20:00 Est Make note: ATXI has been a big trader ever since it's very recent RS......conversely ....FWBI has done the
...more
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 06, 2022 9:23pm
FWBI ..... Is this P.O a good thing or a bad thing u ask ?
To be honest...... 8 times out of 10 the first reaction to the announcement drives the share price down (considerably in alot of cases). On rare occasions... some Co's make the announcement and
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 06, 2022 9:00pm
New Press Release - First Wave BioPharma, Inc. Announces Pricing of $6.0 Million Public Offering
BOCA RATON, Fla., Oct. 06, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases, today announced the...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing